Joseph Lieberman said...

So what happened was that this brilliant idea of ours did not seem so brilliant to the generic drug industry which did n...

That is a great question.

I hope that some of you on the Committee and the Committee itself will think about taking whatever parts of this report ...

Our judgment is that it is an old system, it is using old technology, and, frankly, it is not up to the challenge.